EPM speaks to Shorla Pharma’s CTO Orlaith Ryan about how the company is aiming to be a strong contender in the oncology market through therapies designed for women and children.
Shorla Pharma
Shorla Pharma CTO Orlaith Ryan & CEO Sharon Cunningham
Co-founded in 2018 between CTO Orlaith Ryan and CEO Sharon Cunningham, Shorla Pharma has quickly made a name for itself. The Irish company has been recognised as an emerging company in the oncology sector, being nominated for and winning entrepreneurial awards by the likes of The Irish Times and the Local Enterprise Office.
Back in June 2020, the company raised $8.3 million to help it advance its pipeline of therapies targeting women and paediatric cancers. Oncology may be a competitive sector within pharma, but Shorla is hoping that its approach towards treatments in the space will help it emerge as a serious contender.